期刊
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
卷 14, 期 5, 页码 556-567出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.bbmt.2008.02.019
关键词
acute myeloid leukemia; hematopoietic stem cell transplantation; bone marrow transplantation; reduced intensity; acute leukemia; graft-versus-leukemia effect
Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment of many patients with acute myeloid leukemia (AML). Despite extensive study, the appropriate role and timing of allogeneic and autologous transplantation in AML are poorly defined. This review critically analyzes the extensive literature, focusing on the recent advances, and provides practical recommendations for the use of HSCT in AML. (C) 2008 American Society for Blood and Marrow Transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据